Clinical Trial Update: Effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lambert-eaton Myasthenic Syndrome

Drugs mentioned

• 3,4-Diaminopyridine (3,4-diaminopyridine)

Snippet

Sponsor: Jacobus Pharmaceutical | Conditions: Lambert-Eaton Myasthenic Syndrome, Eaton-Lambert Myasthenic Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2017-07-11